503 First results of diflomotecan, a new topoisomerase 1 inhibitor, as oral soft-gel capsules in a phase I dose escalation study in patients with advanced malignant solid tumours
Ejc Supplements（2004）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要